Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Expert Opinion on Drug Metabolism & Toxicology|July 10, 2018
The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infectionGueorgui Dubrocq, Natella RakhmaninaHIV/AIDS (Auckland, N.Z.)|June 27, 2018
Antiretroviral therapy interruptions: impact on HIV treatment and transmissionGueorgui Dubrocq, Natella RakhmaninaPaediatric Drugs|April 20, 2011
Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challengesB Ryan Phelps, Natella RakhmaninaPediatric Clinics of North America|October 6, 2012
Pharmacotherapy of pediatric HIV infectionNatella Rakhmanina, B Ryan PhelpsSeminars in Fetal & Neonatal Medicine|February 11, 2005
Pharmacotherapy of perinatal HIVEdmund Capparelli, Natella Rakhmanina, Mark MirochnickSeminars in Fetal & Neonatal Medicine|November 21, 2012
Metabolic and mitochondrial effects of antiretroviral drug exposure in pregnancy and postpartum: implications for fetal and future healthBrian Kirmse, Stephen Baumgart, Natella RakhmaninaEclinicalmedicine|July 16, 2024
Cognitive impairment in children and adolescents living with perinatal HIV disease in the ART era: a meta-analysisSophia Dahmani, Natella Rakhmanina, Xiong JiangCurrent Opinion in HIV and AIDS|August 15, 2024
Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?Natella Rakhmanina, Caroline Foster, Allison AgwuPaediatric Drugs|January 12, 2017
Challenges and Opportunities in the Development of HIV Medications in Pediatric PatientsGueorgui Dubrocq, Natella Rakhmanina, B Ryan PhelpsEndocrinology, Diabetes & Metabolism Case Reports|November 10, 2017
Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapyGueorgui Dubrocq, Andrea Estrada, Shannon Kelly, et al.Pageof 7